Zobrazeno 1 - 10
of 129
pro vyhledávání: '"D, Kleinert"'
Autor:
K. Benz, M. Büttner, D. Kleinert, V. Kufer, H. Fehrenbach, J. Velden, Kerstin Amann, C. Bergmann
Publikováno v:
Nieren- und Hochdruckkrankheiten. 42:192-195
Publikováno v:
Transfusion medicine (Oxford, England). 26(3)
Life expectancy of patients with transfusion-dependent thalassemias has increased with the development of improved treatment over the last few decades. However, β-thalassemia disorder still has considerable lifetime treatment demands and heightened
Autor:
Michael R. Meiler, Marc Fisher, Turgut Tatlisumak, Richard A.D. Carano, Christopher H. Sotak, Kentaro Takano, H. D. Kleinert
Publikováno v:
Scopus-Elsevier
Objective: To explore the utility of intravenous (IV) prourokinase treatment, we compared intra-arterial (IA) and IV delivery in a rat embolic stroke model, using diffusion (DWI) and perfusion (PI) magnetic resonance imaging to assess in vivo effects
Autor:
H. D. Kleinert, T. J. Magoc, George W. Carter, Douglas W. Morgan, S. D. Menacherry, James B. Summers, E. Sun, A. E. Reyes, Daniel H. Albert
Publikováno v:
Inflammation Research. 46:272-277
Objective and Design: ABT-299 is a prodrug that is converted by serum esterase to a potent platelet activating factor (PAF) antagonist (A-85783). In order to evaluate the pharmacological activity of this antagonist in man the effect of ABT-299 given
Autor:
H D Kleinert
Publikováno v:
American Journal of Nephrology. 16:252-260
Renin inhibitors may offer an exciting new therapeutic means of blocking the actions of the renin-angiotensin-aldosterone system. These compounds interfere with the first, rate-limiting step in the synthesis of angiotensin II by binding directly to t
Autor:
H D, Kleinert
Publikováno v:
Cardiovascular Drugs and Therapy. 9:645-655
Modification of the renin-angiotensin-aldosterone system by renin inhibitors may be an alternative to angiotensin-converting enzyme inhibitors in the treatment of cardiovascular disease. The development of clinically useful renin inhibitors has been
Autor:
Kenneth P. Spina, Jerome Cohen, Hollis D. Kleinert, William R. Baker, Saul H. Rosenberg, Herman H. Stein
Publikováno v:
Bioorganic & Medicinal Chemistry. 2:927-937
A novel transition-state mimic containing a C-tenninal oxetane has been developed. Renin inhibitors incorporating this fragment exhibit enhanced potency against human plasma renin at physiological pH. The binding affinity of this new species has allo
Publikováno v:
Immunohematology. 26(3)
The DAT is performed for the detection of antibody or complement on the surface of RBCs. Our institution previously performed DATs on all chronically transfused thalassemia patients before each transfusion episode to detect early alloimmunization. Th
Publikováno v:
American Journal of Hypertension. 6:514-521
A-72517 is a potent inhibitor of human renin (IC50 = 1.0 nmol/L, pH 7.4 in plasma) and, aside from displaying modest activity against canine plasma renin (IC50 = 110 nmol/L), has been shown to be orally active in the dog and other animals. Renin inhi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.